Cardiogeni (AQSE:CGNI) OCF Margin %: 0.00% (As of . 20)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Cardiogeni OCF Margin %?

Cardiogeni AQSE:CGNI OCF Margin % is 0.00% as of . 20.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Cardiogeni's Cash Flow from Operations for the six months ended in . 20 was £0.00 Mil. Cardiogeni's Revenue for the six months ended in . 20 was £0.00 Mil. Therefore, Cardiogeni's OCF Margin % for the quarter that ended in . 20 was 0.00%.

As of today, Cardiogeni's current OCF Yield % is 0.00%.

The historical rank and industry rank for Cardiogeni's OCF Margin % or its related term are showing as below:


AQSE:CGNI's OCF Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -67.62
* Ranked among companies with meaningful OCF Margin % only.

Cardiogeni OCF Margin % Related Terms

Cardiogeni OCF Margin % Historical Data

* Premium members only.

The historical data trend for Cardiogeni's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cardiogeni OCF Margin % Chart

Cardiogeni Annual Data
Trend
OCF Margin %

Cardiogeni Semi-Annual Data
OCF Margin %

Cardiogeni OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Cardiogeni's OCF Margin for the fiscal year that ended in . 20 is calculated as

OCF Margin=Cash Flow from Operations (A: . 20 )/Revenue (A: . 20 )
=/
= %

Cardiogeni's OCF Margin for the quarter that ended in . 20 is calculated as

OCF Margin=Cash Flow from Operations (Q: . 20 )/Revenue (Q: . 20 )
=/
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of 0.00% mean?
Cardiogeni (AQSE:CGNI) has a OCF Margin % of 0.00% as of . 20. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Cardiogeni and its competitors.
Is Cardiogeni's OCF Margin % too high?
Cardiogeni's current OCF Margin % is 0.00%.
How does Cardiogeni's OCF Margin % compare to ?
Cardiogeni's OCF Margin % of 0.00% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Biotechnology company?
A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Cardiogeni and its competitors. Cardiogeni's current OCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cardiogeni stock overvalued right now?
Cardiogeni (AQSE:CGNI) has a current OCF Margin % of 0.00%. The current OCF Margin % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Cardiogeni (AQSE:CGNI), the current OCF Margin % is 0.00% as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Cardiogeni Business Description

Comparable Companies
Address Celixir House Stratford-Upon-Avon Business & Technology Park, Innovation Way, Stratford upon Avon, GBR, CV37 7GZ
Cardiogeni PLC is engaged in the development and commercialisation of a portfolio of novel cellular medicines for heart failure. The Company focuses on the development and commercialisation of novel cellular medicines targeting early- and mid-stage heart failure. Its strategic priority is to complete a pivotal Phase 2b/3 study and obtain first market approval for its product, CLXR-001, in a suitable jurisdiction, and then establish strategic funding and collaboration agreements to develop and commercialise the product in the US, EU, Japan, and other jurisdictions.